Zurich Insurance Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Zurich Insurance Group’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.9M	Sell	44,618 -4,081	-8%	-$1.9M	0.16%	161
2025 Q4	$22.1M	Buy	+48,699	New	+$21M	0.15%	145
2025 Q3	–	Sell	-52,372	Closed	-$23.3M	–	332
2025 Q2	$23.3M	Sell	52,372 -157,534	-75%	-$72.6M	0.18%	108
2025 Q1	$102M	Buy	209,906 +158,379	+307%	+$73.8M	0.82%	37
2024 Q4	$20.7M	Sell	51,527 -1,735	-3%	-$804K	0.17%	122
2024 Q3	$24.8M	Sell	53,262 -38,056	-42%	-$18.3M	0.21%	112
2024 Q2	$42.8M	Buy	+91,318	New	+$39.6M	0.37%	78
2024 Q1	–	Sell	-185,815	Closed	-$75.6M	–	292
2023 Q4	$75.6M	Sell	185,815 -50,359	-21%	-$18.6M	0.77%	43
2023 Q3	$82.1M	Sell	236,174 -59,758	-20%	-$20.9M	0.87%	32
2023 Q2	$104M	Buy	+295,932	New	+$99.7M	1.08%	25
2019 Q4	–	Sell	-46,850	Closed	-$7.94M	–	477
2019 Q3	$7.94M	Buy	46,850 +1,554	+3%	+$275K	0.15%	167
2019 Q2	$8.31M	Buy	45,296 +1,779	+4%	+$311K	0.16%	175
2019 Q1	$8.01M	Sell	43,517 -31,257	-42%	-$5.77M	0.17%	171
2018 Q4	$12.4M	Buy	74,774 +2,412	+3%	+$418K	0.3%	101
2018 Q3	$13.9M	Buy	72,362 +33,572	+87%	+$5.98M	0.3%	100
2018 Q2	$6.59M	Sell	38,790 -15,357	-28%	-$2.38M	0.15%	204
2018 Q1	$8.82M	Buy	54,147 +16,644	+44%	+$2.72M	0.2%	134
2017 Q4	$5.62M	Buy	37,503 +4,603	+14%	+$682K	0.13%	185
2017 Q3	$5M	Sell	32,900 -4,433	-12%	-$667K	0.14%	182
2017 Q2	$4.81M	Sell	37,333 -8,268	-18%	-$995K	0.14%	181
2017 Q1	$4.99M	Sell	45,601 -2,209	-5%	-$194K	0.14%	175
2016 Q4	$3.52M	Buy	47,810 +5,181	+12%	+$422K	0.11%	233
2016 Q3	$3.72M	Buy	42,629 +26,534	+165%	+$2.51M	0.12%	201
2016 Q2	$1.38M	Buy	+16,095	New	+$1.39M	0.05%	299

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Zurich Insurance Group's VRTX Position: Q1 2026 in Review

Zurich Insurance Group reduced its Vertex Pharmaceuticals (VRTX) stake by 8.4% in Q1 2026, selling an estimated $1.9M and leaving 44,618 shares worth $19.9M. The position accounts for 0.16% of the portfolio, ranked #161.

Zurich Insurance Group first reported a position in VRTX in Q2 2016 and has held it in 24 quarters since. The position peaked at $104M in Q2 2023. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Zurich Insurance Group held 44,618 shares of Vertex Pharmaceuticals worth $19.9M as of Q1 2026.
Zurich Insurance Group sold 4,081 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.9M.
Vertex Pharmaceuticals made up 0.16% of Zurich Insurance Group's portfolio in Q1 2026, its #161 holding.
Zurich Insurance Group first reported a position in Vertex Pharmaceuticals in Q2 2016 and has held it in 24 quarters since.
Zurich Insurance Group's Vertex Pharmaceuticals position peaked at $104M in Q2 2023.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Zurich Insurance Group's 13F filing for Q1 2026, filed 15 May 2026.